Table 2.

Medications by Statin Use Before and After PS Matching in Patients With LDL‐C Levels ≤113 mg/dL

	Statins Before PS Match			Statins After PS Match
	No, n = 1067	Yes, n = 2296	P Value	No, n = 1031	Yes, n = 1031	P Value
Previous medications
Antiplatelet agents	139 (13.0)	234 (10.2)	0.015	130 (12.6)	133 (12.9)	0.843
β‐Blockers	78 (7.3)	134 (5.8)	0.102	72 (7.0)	71 (6.9)	0.931
ACEIs/ARBs	98 (9.2)	141 (6.1)	0.001	94 (9.1)	91 (8.8)	0.817
CCBs	101 (9.5)	207 (9.0)	0.674	99 (9.6)	103 (10.0)	0.767
Diuretics	59 (5.5)	92 (4.0)	0.047	50 (4.8)	45 (4.4)	0.599
Nitrates	67 (6.3)	85 (3.7)	0.001	59 (5.7)	63 (6.1)	0.709
In‐hospital medications
Antiplatelet agents	1050 (98.4)	2284 (99.7)	<0.001	1026 (99.5)	1022 (99.3)	0.560
β‐Blockers	705 (66.1)	1704 (74.3)	<0.001	693 (67.2)	715 (69.5)	0.268
ACE‐Is/ARBs	810 (75.9)	1904 (83.1)	<0.001	793 (76.9)	800 (77.7)	0.653
Heparin	808 (75.7)	1836 (80.1)	0.004	785 (76.1)	781 (75.9)	0.898
CCBs	163 (15.3)	277 (12.1)	0.011	154 (14.9)	150 (14.6)	0.818
Diuretics	380 (35.6)	686 (29.9)	0.001	358 (34.7)	368 (35.8)	0.622
Nitrates	758 (71.0)	1625 (70.9)	0.933	737 (71.5)	721 (70.1)	0.480
Discharge medications
Antiplatelet agents	937 (97.3)	2198 (99.1)	<0.001	929 (98.3)	954 (97.9)	0.561
β‐Blockers	643 (66.8)	1577 (71.1)	0.015	635 (67.2)	671 (68.9)	0.426
ACEIs/ARBs	737 (76.5)	1862 (83.9)	<0.001	729 (77.1)	742 (76.2)	0.618
CCBs	130 (13.5)	249 (11.2)	0.071	124 (13.1)	122 (12.5)	0.696
Diuretics	244 (25.3)	510 (23.0)	0.153	238 (25.2)	251 (25.8)	0.769
Nitrates	496 (51.5)	1050 (47.3)	0.033	482 (51.0)	491 (50.4)	0.794

Abbreviations: ACEI, angiotensin‐converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; LDL‐C, low‐density lipoprotein cholesterol; PS, propensity score.

Data are expressed as n (%).